Omeprazole

奥美拉唑

Report date: 2026/02/24 20:00:16
NME

Base Information

Drug NameOmeprazole
Drug Alias Name洛赛克omeprazolomeprazolum奥美拉挫Ulzol +[27] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsHelicobacter pylori infectionhyperchlorhydriaHeartburn +[16] 
Global Approved IndicationsHelicobacter pylori infectionhyperchlorhydriaHeartburn +[6] 
Approved Indications in ChinahyperchlorhydriaStomach UlcerGastroesophageal Reflux
Original Approved Country/TerritoryJapan
Original Approved Date1991/04/01
Country/TerritoryUnited StatesHong KongMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTaiyo Pharma Co ltdWake Forest University Health SciencesAcino Pharma Gmbh +[8] 
Inactive CompaniesChinese University Of Hong Kong (Cuhk)Astrazeneca Pharmaceutical Co LtdAssiut University +[7] 
Active IndicationsHelicobacter pylori infectionhyperchlorhydriaHeartburn +[10] 
Inactive IndicationsPeptic Ulcer HemorrhageEosinophilic EsophagitisZollinger-Ellison Syndrome +[6] 

Other Information

ATC CodeA02BC01
Related LinksWikipediaDrugBankKEGG